Tissuecypher® provides clinically-impactful risk stratification in patients with barrett's esophagus

Friendswood, texas--(business wire)---- $cstl #barretsesophagus--castle will share new data on its tissuecypher® test during the presidential plenary session of the 19th isde world congress for esophageal diseases.
CSTL Ratings Summary
CSTL Quant Ranking